Skip to content

Illumina Inc Sustainability Reports

Illumina, Inc. develops, manufactures, and markets integrated systems for the large-scale analysis of genetic variation and biological function. The company provides a line of DNA sequencing and array-based technologies used across life sciences, oncology, and reproductive health markets.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: SQ95QG8SR5Q56LSNF682

FIGI: BBG001SF4NY1

29 reports from 2006 to 2025